BofA raised the firm’s price target on Albertsons (ACI) to $24 from $22 and keeps a Neutral rating on the shares. The firm noted that Q3 adjusted earnings per share was ahead of the Street, with the company updating its FY25 guidance given Q3 upside and ongoing benefits from increasing productivity. BofA added that it believes Albertsons’ focus on building customer lifetime value through pharmacy, digital, and loyalty initiatives supports its long-term outlook, though pharmacy mix/margin pressures and investments in digital could limit near-term upside.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACI:
- Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz
- ACI Earnings: Albertsons (NYSE:ACI) Q3 Earnings Beat after Dropping Kroger Deal
- Morning Movers: AngioDynamics jumps following results and guidance raise
- Albertsons raises FY24 adjusted EPS view to $2.25-$2.31 from $2.20-$2.30
- Albertsons reports Q3 adjusted EPS 71c, consensus 65c
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
